Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

v3.21.2
Stockholders' Equity (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Jun. 05, 2021
Jun. 30, 2019
Aug. 01, 2021
Aug. 02, 2020
Aug. 01, 2021
Aug. 02, 2020
Stockholders' Equity (Details) [Line Items]            
Cashless warrant exercised (in Shares)         5,625  
Number of expired warrants (in Shares)         98  
Stock options are subject to vesting percentage   100.00%        
Stock price $ 75 $ 75        
Stock option modified (in Shares)   495,366        
Additional compensation   $ 874,000        
Modification and remaining expense was recognized   $ 315,000        
Stock-based compensation         $ 200,000  
Equity based compensation expense     $ 1,100,000 $ 700,000 1,800,000 $ 1,600,000
Total unrecognized equity based compensation cost related to unvested stock option and restricted unit awards     $ 6,100,000   $ 6,100,000  
Weighted average period         1 year 10 months 20 days  
2017 Equity Incentive Plan [Member]            
Stockholders' Equity (Details) [Line Items]            
Granted term         10 years  
Common stock reserved issuance (in Shares)     2,104,889   2,104,889  
Non statutory stock options granted (in Shares)   495,366        
Stock option price exercise (in Dollars per share)   $ 38.10        
Warrant [Member]            
Stockholders' Equity (Details) [Line Items]            
Issuance of common shares (in Shares)         10,956